I think the potential of Agenic is to rethink how work gets done overall.

It challenges all sorts of traditional orthodoxies around how organizations execute the work at hand.

That's Jason Gersatus, CEO of Deloitte U.S., talking about the transformational potential of A.Gentic AI.

Join him later to learn why agents are a game changer for businesses across industries.

Here's your midday brief for Monday, February 9th. I'm Alex Zosolet for the Wall Street Journal.

Grocery giant Kroger has named Greg Forren as its new CEO. He's a former executive at Walmart, a top rival. Kroger's the

biggest grocer in the U.S. by sales after Walmart. It's been searching for a permanent

leader for almost a year. Its longtime CEO Rodney McMullen had left last spring for an

undisclosed ethics violation. Kroger shares were up about 6% in morning trading.

The operator of Eddie Bauer's stores in the U.S. and Canada has filed for bankruptcy.

The company is seeking a buyer for the retail locations and will begin winding down

store operations if a sale doesn't go through.

Eddie Bauer has been in a tough spot for years.

It's faced declining sales, supply chain challenges, and other issues. And Novo Nordisk has been in a tough spot for years. It's faced declining sales, supply chain challenges, and other

issues. And Novo Nordisk has filed a lawsuit against Hems and HERS to stop the telehealth

provider from selling copycat versions of its popular weight loss drugs. The Danish

drug maker says the versions of the medications that Hymns and HERS sells don't come under the FDA's gold

standard safety review process. It's seeking damages in its suit. Hymns and Hurs said the Danish

company's actions could be detrimental to patients who rely on compounded medications. This morning,

we reported that Hymns and Hurs had backtracked on its plan to offer a cheaper knockoff version of

Novo's new Wagovi weight loss

pill. Heads up, an artificial intelligence tool helped us make this episode by creating summaries

...